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Abstract 
Aims: We have previously demonstrated that absence of functional GABA B receptors 
(GABABRs) disturbs glucose homeostasis in GABAB1KO mice. The aim of this work 
was to extend our studies of these alterations in GABAB1KO mice and investigate the 
sexual differences therein. 
Main Methods: Male and female, GABAB1KO and WT mice were used. Glucose and 
insulin tolerance tests (GTT and ITT), and insulin and glucagon secretion tests (IST and 
GST) were performed. Blood glucose, serum insulin and hyperglycemic hormones were 
determined, and HOMA-IR calculated. Skeletal muscle insulin receptor  subunit (IR, 
insulin receptor substrates 1/2 (IRS1, IRS2) and hexokinase-II levels were determined 
by Western Blot. Skeletal muscle insulin sensitivity was assessed by in vivo insulin-
induced Akt phosphorylation (Western Blot). Food intake and hypothalamic NPY 
mRNA expression (by qPCR) were also evaluated. 
Key Findings: Fasted insulin and HOMA-IR were augmented in GABAB1KO males, 
with no alterations in females. Areas under the curve (AUC) for GTT and ITT were 
increased in GABAB1KO mice of both genders, indicating compromised insulin 
sensitivity. No genotype differences were observed in IST, GST or in IR, IRS1, IRS2 
and hexokinase-II expression. Akt activation was severely impaired in GABAB1KO 
males while no alterations were observed in females. GABAB1KO mice showed 
increased food intake and NPY expression. 
Significance: Glucose metabolism and energy balance disruptions were more pronounced 
in GABAB1KO males, which develop peripheral insulin resistance probably due to 
augmented insulin secretion. Metabolic alterations in females were milder and possibly 
due to previously described reproductive disorders, such as persistent estrus. 
Keywords: insulin resistance; food intake; Akt activation; GABAB1KO mice
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Introduction 
Type 2 diabetes (T2D) involves chronic dysregulation of glucose metabolism and 
impaired insulin sensitivity. More than 80% of patients progressing to T2D are 
hyperinsulunemic and insulin resistant (Pal 2009). In T2D, defects in insulin-stimulated 
glucose uptake in skeletal muscle are major factors inducing impaired glucose 
homeostasis, including alterations in protein expression, enzyme activation/deactivation 
or sensitivity to endogenous ligands. 
GABA, the main inhibitory neurotransmitter in the brain, is found at high 
concentrations in Langerhans islets (Franklin and Wollheim 2004). Although a 
complete islet GABA system was demonstrated, the role of GABA in pancreatic 
physiology is less characterized. GABA inhibits high glucose-stimulated insulin 
secretion through GABAB receptors (GABABRs) in MIN6 cells and in rat/mouse islets 
(Bonaventura et al. 2012; Braun et al. 2004; Brice et al. 2002). We have recently 
described that GABAB agonists and antagonists alter glucose homeostasis in mice 
(Bonaventura et al. 2012). Previously we demonstrated that absence of functional 
GABABRs in GABABR knock-out mice (GABAB1KO) induced high pancreas insulin 
content and insulin resistance (Bonaventura et al. 2008). 
Regarding insulin signaling, it binds to its receptor (IR), which is autophosphorylated 
and in turn phosphorylates IRS1 and IRS2. pIRS1/2 activate phosphoinsitol PI-3-kinase 
(PI3K) (Okada et al. 1994) which activates protein kinase B (PKB/Akt) (Franke et al. 
1997). Akt is the major effector exerting the metabolic effects of insulin, including 
glucose transport, glycogen synthesis, fat deposition and protein synthesis. Loss of Akt 
signaling leads to glucose homeostasis impairment (Saltiel and Kahn 2001).  
In addition to insulin, other hormones involved in blood glucose control are glucagon, 
growth hormone (GH) and corticosterone. GH increases plasma glucose by decreasing 
peripheral glucose uptake. An increased GABAergic tone inhibits GH secretion 
(Tuomisto and Mannisto 1985). Moreover, somatotropes express GABABRs 
(Mayerhofer et al. 2001) and stimulation of pituitary GABABRs increases GH secretion 
(Gamel-Didelon et al. 2002). Glucagon is secreted by -cells in response to low blood 
glucose and its secretion is inhibited by insulin. Wendt et al. (Wendt et al. 2004) 
demonstrated that GABA released from -cells inhibits glucagon release from -cells in 
rat pancreas, confirming results in mice (Gilon et al. 1991). Ohers proposed that insulin 
sensitized -cells to -cell-secreted GABA (Xu et al. 2006). Cortisol increases blood 
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glucose by inhibiting glucose uptake and utilization; it also stimulates appetite and 
changes fat metabolism (van Raalte et al. 2009). As GABA, through GABABRs, alters 
the corticotropic axis (Marques and Franci 2008), it could modulate the hyperglycemic 
effects of cortisol.  
GABA is also considered an orexigenic stimulus (King 2006), and a role for central 
GABABRs controlling food intake has been suggested (Ebenezer and Prabhaker 2007). 
Neuropeptide Y (NPY), is expressed in the arcuate nucleus, and is a potent stimulant of 
food intake. Evidences suggest that the anorexigenic effects of insulin are exerted by 
inhibition of NPY in the arcuate, acting through GABAARs and GABABRs present in 
NPY neurons (Sato et al. 2005). 
Therefore, here we evaluated how the lack of functional GABABRs affects different 
targets participating in blood glucose control in GABAB1KO mice and the sexual 
differences therein. 
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Materials and Methods 
Animals. GABAB1KO mice, generated in the BALB/C inbred strain (Schuler et al. 
2001), were obtained by intercrossing heterozygous animals and the day of birth was 
recorded. Mice were genotyped by PCR analysis, as described previously (Catalano et 
al. 2005). Animals were fed ad libitum. All studies were performed according to 
protocols for animal use, approved by the Institutional Animal Care and Use Committee 
(IBYME-CONICET) that follows the NIH guidelines. Adult 2-3 month-old female and 
male WT and GABAB1KO mice were used. For each experimental design animals 
were age-matched littermates. Animals were sacrificed by decapitation in minimal 
conditions of stress. 
Basal blood glucose titers and glucose tolerance test. Blood glucose was measured by 
a One touch® Ultra™ glucose meter (Lifescan, Scotland Ltd, strips were kindly 
donated by Johnson & Johnson, Argentina) from tail blood. For the glucose tolerance 
test (GTT) intraperitoneal (ip) glucose (3 g/kg body weight (BW) (Bonaventura et al. 
2008)) was injected to overnight fasted mice (15-18 h) and blood glucose was 
evaluated at 0, 30, 60 and 75 minutes post glucose administration. Results were 
informed as Area under the curve (AUC). 
Insulin determination and insulin secretion test (IST). Serum insulin was measured with 
an Ultrasensitive insulin mouse ELISA kit (Chrystalchem, Chicago, Il) at 0, 10, 20, 30 
and 60 min after the ip glucose injection of 3 g/kg BW in mice fasted for 15-18 h in 
samples taken during the GTT. Results were informed as AUC. 
HOMA index calculation. HOMA of insulin resistance (HOMA-IR) was calculated with 
basal blood glucose and basal insulin measured after overnight fasting, as previously 
decribed (Bonaventura et al. 2012). HOMA-IR= Fasting insulin (U/ml) x Fasting 
glucose (mmol /L) / 22.5. 
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Insulin tolerance test (ITT). Blood glucose was measured as above in 2-4 h fasted 
mice after 0, 10, 20, 30 and 60 min of an ip injection of 1 U/kg BW of porcine 
humanized insulin (a gift from Laboratorios Beta, Buenos Aires, Argentina). Results 
were informed as AUC. 
Glucagon secretion test (GST). 3-4 h fasted animals were injected with insulin (1U/kg 
i.p.) and blood was collected from tail at 0 and 30 min post-injection (Zhou et al. 2004). 
Glucagon was determined by RIA (Glucagon RIA KIT, Millipore, MA) according to 
the manufacturer protocol. Results were informed as AUC. 
Basal hyperglycemic serum hormones determinations. Glucagon was determined by 
RIA, as above. For corticosterone determination, serum samples were extracted with 
dichloromethane and corticosterone content determined by RIA, as previously described 
(Bonaventura et al. 2012; Repetto et al. 2010). Growth hormone (GH) was also 
determined by RIA, as previously described (Catalano et al. 2005). 
In vivo peripheral tissue response to insulin. Fasted animals (2-4 hs) were anesthetized 
with avertin 2% (12 ml/kg i.p.). The abdominal cavity was opened, the portal vein 
exposed, and 2 U/kg of insulin was injected (in 0.5 ml saline) into the portal vein. At 
time points 0, 1 and 5 minutes post-injection, portions of skeletal muscle were excised 
and flash frozen in liquid N2 and stored at -70ºC until used. Tissues were disrupted in 10 
volumes of lysis buffer (1% SDS, NaCl, 10 mM EDTA, Tris.HCl) containing 
phosphatases and proteases inhibitors (LiCl, Na3VO4, PMSF, ZPCK, TAME, TPLC, -
glicerolphosphate) at 4ºC with a Polytron homogenizer, samples were centrifuged at 
10000 rpm and pellets discarded. Supernatants were kept frozen until used. 
Western Blot analysis. Western blot analysis for IRS1, IRS2, IR subunit, hexokinase-
II, pAkt, Akt, and actin were performed in skeletal muscle homogenates of WT and 
GABAB1KO of both genders. 50 g of proteins and biotinylated molecular weight 
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markers were subjected to 8% SDS-PAGE and proteins were transferred onto 
nitrocellulose membranes. Non specific protein binding to nitrocellulose was reduced 
by preincubating membranes with 5% non-fat milk in 0.5% Tween PBS (PBS-T). For 
IRS-1, IRS-2 and IRmembranes were incubated over night (ON) at 4ºC with the first 
antibody diluted in PBS-T, 5% non-fat milk (Millipore, CA, IRS1, cat # 06-248: 1:500, 
IRS2, cat # 06-506: 1:500; IRcat # 07-724: 1:125) followed by 2 hs incubating with 
HRP conjugated anti-rabbit (Vector, CA, cat # PI-1000:  1:3000) and anti-biotin (Cell 
Signalling, MA, cat # SP-3010: 1:4000) in PBS-T, 1% BSA, at room temperature (RT). 
For Hexokinase-II, membranes were incubated ON at 4ºC with first antibody generated 
in rabbit diluted in PBS-T, BSA 1% (Cell Signalling, cat # 2867: 1:500) followed by 
incubation with second antibody as described above. Membranes were stripped with 
stripping buffer (Tris-HCl 62,5 mM, SDS 2%, β-mercaptoethanol 100 mM, pH=6.7) 
and re-used for actin determination: membranes were incubated 1 h with mouse 
generated first antibody diluted in PBS-T, BSA 2% (Sigma, MI, cat # CP01: 1:5000) 
followed by incubation with HRP conjugated anti-mouse (Vector, CA, cat # PI-2000: 
1:3000) and anti-biotin (Cell Signalling 1:4000) in PBS-T, 1% BSA, at RT. 
For p-Akt, membranes were incubated ON at 4ºC with first antibody generated in rabbit 
diluted in PBS-T, BSA 5% (Cell Signalling, MA, cat # 9271: 1:1000) followed by 
incubation with second antibody as described above. Membranes were stripped, as 
described, and re-used for Akt; membranes were incubated 1 h with goat generated first 
antibody diluted in PBS-T, 1% BSA (Santa Cruz Biotechnology Inc, CA, cat # sc-1618: 
1:500) followed by 1 h incubation with HRP conjugated anti-goat (Santa Cruz 
Biotechnology Inc, CA, cat # sc-2953: 1:4000) and anti-biotin (Cell Signalling 1:4000) 
in PBS-T, 1% BSA, at RT. 
Detection was performed using an enhanced chemiluminescence Western Blot analysis 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 8 
system (Western Blotting Chemiluminescence Luminol Reagent, Santa Cruz 
Biotechnology) followed by image analysis with G-Box documentation system 
(Syngene, Unitek, BA). 
Body weight and food intake. Body weight (BW) and food intake were monitored. Food 
intake was informed relative to body weight (g of food/g BW). 
Expression of NPY in medial basal hypothalamus (MBH). To determine NPY expression by 
qRT-PCR, total RNA was isolated from homogenates of MBH, excised as previously 
described (Catalano et al. 2010). RNAs were obtained using TRIZOL reagent (Invitrogen, 
CA) according to the manufacturer’s protocol and kept at -70ºC until used. The RNA 
concentration of all final preparations was calculated using the Qubit Quantitation Platform 
(Invitrogen) according to the manufacturer’s protocol. First strand cDNA was synthesized 
from 2 µg of total RNA in the presence of 10 mM MgCl2, 50mM Tris–HCl (pH 8.6), 75 
mM KCl, 0.5 mM deoxy-NTPs, 1 mM DTT, 1 U/µl RnaseOUT (Invitrogen), 0.5 µg 
oligo(dT)15 primer (Biodynamics, BA), and 20 U of MMLV reverse transcriptase 
(Epicentre, WI). To ensure absence of genomic DNA the reverse transcriptase was omitted 
in control reactions. The absence of PCR-amplified DNA fragments in these samples 
indicated the isolation of RNA free of genomic DNA. For quantitative real-time PCR 
oligonucleotide primers sequence used were as follows: cyclophilin sense 
GTGGCAAGATCGAAGTGG, cyclophilin antisense TAAAAATCAGGCCTGTGG; 
NPY sense GATGCTAGGTAACAAGCGAATG, NPY antisense 
TCAGCCAGAATGCCCAAAC (Garcia-Tornadu et al. 2009). Quantitative measurements 
of cDNA were performed by kinetic PCR using SYBR
®
 Green PCR Master Mix (Applied 
Biosystems, UK) according to the manufacturer’s protocol, with an annealing step at 58ºC, 
40 s. and an appropriate dilution of cDNA in a final volume of 13 l. 
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The accumulating DNA products were monitored by the ABI7500 sequence detection 
system (Applied Biosystems), and data were stored continuously during the reaction. 
The results were validated based on the quality of dissociation curves, generated at the 
end of the PCR runs by ramping the temperature of the samples from 60°C to 95°C, 
meanwhile continuously collecting fluorescence data. Product purity was confirmed by 
2% agarose gel electrophoresis. Each sample was analyzed in triplicate along with non-
template controls to monitor contaminating DNA. The relative gene expression was 
normalized to that of cyclophilin housekeeping gene using the comparative method of  
ΔΔCt, described by the Livak & Schmittgen (Livak and Schmittgen 2001). 
Results are expressed as arbitrary units (AU) for comparison among samples. AU is defined 
as the expression level relative to a sample of wildtype male mice (calibrator sample). 
Statistical analysis. All results are expressed as means ± SEM. Statistical analyses were 
performed with Statistica Six Sigma Edition. The differences between means were 
analyzed by one-way or two-way ANOVA, followed by Newman-Keuls test or Tukey 
HSD test for unequal N. For multiple determinations in the same animal, two–way 
ANOVA with repeated measures design was used, followed by the same post-hoc tests. 
p<0.05 was considered statistically significant. 
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Results 
Blood glucose and serum insulin. Fasted and non-fasted glycemia and insulinemia are 
summarized in table I. Fasted insulin was significantly higher in GABAB1KO male 
mice, (Two-way ANOVA, factors genotype and sex, interaction: p<0.04, GABAB1KO 
males significantly different from all the other groups, p<0.01 or less), but no 
differences in fasted glycemia were observed among groups. When calculating HOMA-
IR, we observed a significant increase of this index in male GABAB1KO mice, pointing 
to the development of insulin-resistance in this group (Two-way ANOVA, factors 
genotype and sex, interaction: p<0.03, GABAB1KO males significantly different from 
all the other groups, p<0.03 or less). No HOMA-IR alterations were observed in 
females. In non-fasted mice only sex differences in blood glucose and serum insulin 
were observed (males > females for both parameters) without genotype differences. 
Evaluation of blood glucose regulation. Since HOMA-IR was altered in male 
GABAB1KO mice, we performed functional tests to evaluate the clearance of serum 
glucose in a GTT, the glucose-induced insulin secretion in an IST, the insulin-induced 
glucagon release in a GST, and the peripheral insulin sensitivity in an ITT. The area under 
the curve (AUC) for each of these dynamic tests is shown in Fig. 1. The GTT was altered 
in GABAB1KO mice (Fig. 1A), showing an increase of AUC both in male and females 
with respect to their WT controls, in addition to a sex difference (males > females) (Two-
way ANOVA, interaction: ns, factor genotype: p<0.01, factor sex: p<0.02). These results 
indicate that the clearance of glucose form blood is impaired in GABAB1KO mice. To 
define whether these alterations are due to reduced insulin secretion or to diminished 
insulin sensitivity, we performed the IST and ITT. The IST AUC was not altered in 
GABAB1KO mice with regard to their same sex controls; a statistically significant sex 
differences was observed in the IST AUCs, males > females, in both genotypes (Fig. 1B). 
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However, insulin sensitivity was diminished in GABAB1KO mice, since AUCs of ITTs 
were increased in this genotype (Fig. 1C); in addition a gender difference was also 
observed (males > females) (Two-way ANOVA, interaction: ns, factor genotype: p<0.01, 
factor sex: p<0.01). This result indicates that, in response to the same insulin stimulus, 
depuration of glucose from blood is impaired in GABAB1KO mice. Finally, we found no 
genotype alterations in the GST in response to insulin although GST AUCs were 
increased in females with regard to males (Fig. 1D) (Two-way ANOVA, interaction: ns, 
factor genotype: ns, factor sex: p<0.01), suggesting that alterations in glucagon secretion 
were not involved in the observed phenotype in GABAB1KO mice. 
Evaluation of hyperglycemic hormones. When analyzing other hormones involved in 
the control of glucose homeostasis, we found diminished serum corticosterone levels in 
GABAB1KO respect to WT females (Fig. 2A). In addition, in GABAB1KO mice the 
expected sex difference observed in WTs (females > males) had disappeared. GH and 
glucagon showed neither sex nor genotype differences (Fig. 2B and C, respectively). 
Expression of proteins involved in the insulin signaling pathway in peripheral tissue. 
Since dynamic tests showed an alteration of peripheral insulin sensitivity, we evaluated 
the insulin signaling pathway on skeletal muscle, the main tissue involved in glucose 
depuration. We first evaluated the expression of main proteins involved on this cascade, 
finding no differences in basal expression of IRS1, IR2, IRβ or hexoquinase (Fig. 3A, 
3B, 3C and 3D, respectively). 
Insulin-induced Akt phophorylation. Activation of Akt is the key event responsible for 
the increase in insulin-induced glucose uptake by skeletal muscle. Activation of Akt 
(Fig. 4) showed no genotype alterations in females (Two way ANOVA, interaction: ns, 
factor genotype: ns, factor time: p<0.01, time 0 min: significantly different from 1 and 5 
min, p<0.01). In contrast, in GABAB1KO males phosphorylation of Akt was markedly 
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impaired at 5 minutes post insulin administration (Two way ANOVA, interaction: 
p<0.04, WT males at 5 min: significantly different from 0 and 1min, p<0.02 and also 
significantly different from GABAB1KO males at 5 min, p<0.01).  
Body weight, food intake and NPY expression. Figure 5 shows food intake relative to 
BW and expression of NPY mRNA of animals in this study. GABAB1KO mice show 
increased food intake compared to WTs (Fig. 5A) (Two way ANOVA, factors genotype 
and sex, interaction: ns, factor genotype: p<0.05). Despite this increase, no genotype 
differences were found in body weight (not shown), as previously described (Catalano 
et al. 2005). Interestingly, expression of NPY mRNA was also altered in GABAB1KO 
mice, being significantly higher than in WT mice (Fig. 5B) (Two way ANOVA, factors 
genotype and sex, interaction: ns, factor genotype: p<0.05). 
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Discusion 
The worldwide rise in the incidence of obesity, metabolic syndrome and diabetes, and 
the increasing costs in the management of these diseases and their complications require 
a comprehensive knowledge of the factors regulating glucose homeostasis in order to 
advance in the treatment of these disorders. 
GABA is present at high concentrations in Langerhans islets and its participation in islet 
physiology is multifactorial, including actions in cell metabolism and viability (Ligon et 
al. 2007; Soltani et al. 2011; Sorenson et al. 1991; Winnock et al. 2002) and species-
specific autocrine and paracrine effects on hormone release (Bonaventura et al. 2008; 
Braun et al. 2004; Braun et al. 2010; Brice et al. 2002; Robbins et al. 1981; Soltani et al. 
2011; Wendt et al. 2004; Xu et al. 2006). 
We have demonstrated that GABAB agonists and antagonists, administered both 
acutely or chronically, disturb the regulation of glucose homeostasis in BALB/C mice 
(Bonaventura et al. 2012). In addition, we reported that the absence of functional 
GABABRs in male GABAB1KO mice revealed signs of insulin resistance and 
increased pancreas insulin content (Bonaventura et al. 2008). As sex differences in the 
incidence of diabetes has been reported in various animal models such as NOD mice 
(Rosmalen et al. 2001) and STZ-induced diabetes (Vital et al. 2006) here we performed 
an in depth study of the alterations in the glucose homeostasis regulation in 
GABAB1KO mice comparatively in both genders. 
There were no genotypes differences in blood glucose or serum insulin in animals in 
non-fasting state. However, fasted insulin was significantly increased in GABAB1KO 
males, while maintaining euglycemia. The presence of hyperinsulinemia accompanied 
by euglycemia suggests a reduced sensitivity to insulin of peripheral tissues. This 
phenomenon is further put into evidence by HOMA-IR index, which was significantly 
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increased in GABAB1KO males, as also reported in another model of insulin resistance 
(Maiztegui et al. 2009). Supporting this hypothesis, GABAB1KO males also showed 
impaired ITTs, indicating decreased glucose depuration. Putting these results together, it 
can be inferred that GABAB1KO males developed an impaired glucose tolerance 
derived from diminished insulin sensitivity in peripheral tissue. The sustained, 
increased, fasted insulin secretion observed in GABAB1KO males, due to the absence 
of functional GABABRs, which is in agreement with increased pancreas insulin content 
described previously (Bonaventura et al. 2008), may induce, over time, insulin 
resistance in peripheral tissues, as described in functional insulinomas, in which 
alterations in insulin receptor splice variants, signaling, and binding have been 
demonstrated (Nankervis et al. 1985; Sbraccia et al. 1996; Skrha et al. 1996). In this 
line, in mouse C2C12 muscle cells constant insulin stimulus triggered insulin resistance 
(Kumar and Dey 2003; Rui et al. 2001), which was evidenced by decreased expression 
and/or phosphorylation of different elements of the insulin signaling cascade. 
Given the evidence that GABAB1KO male mice develop insulin resistance 
spontaneously, we evaluated whether any elements of the insulin signaling cascade were 
altered in these animals, especially in skeletal muscle, the main tissue involved in the 
insulin-stimulated-glucose uptake from blood. No differences in the expression of IR, 
IRS1/2 and hexokinase-II were observed in our model. Interestingly, several studies 
have shown that the number and function of the insulin receptors are normal or slightly 
reduced in patients and animal models of insulin resistance, and that this is not 
sufficient to explain the marked reduction in insulin function, thus suggesting that major 
alterations are downstream the receptor (Draznin 2006). Therefore, we then assessed the 
activation of Akt, the main effector in the cascade that leads to membrane translocation 
of glucose transporter in muscle (GLUT-4). We observed that the insulin-induced Akt 
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phosphorylation was profoundly impaired in GABAB1KO males compared to their WT 
controls. This result is in agreement with other authors who report a decrease in insulin-
stimulated Akt phosphorylation in skeletal muscle of mice spontaneously developing 
glucose intolerance and insulin resistance (Oh et al. 2008). Thus, this severely 
diminished activation of Akt could justify the insulin resistance observed in 
GABAB1KO males. Conversely, no alterations were found in hyperglycemic hormones 
such as glucagon, GH and corticosterone between genotypes in male mice. 
In GABAB1KO females, glycemia and serum insulin were normal in both the fasting 
and non-fasting states. Furthermore, we found no alterations in the HOMA-IR index, as 
opposed to GABAB1KO males. However, results from ITTs and GTTs are somewhat 
puzzling, since they are compatible with diminished insulin sensitivity of peripheral 
tissues. The hyperglycemic hormones studied showed diverse results in females; GH 
and glucagon showed no differences between genotypes, but corticosterone was altered 
in GABAB1KOs. Corticosterone was augmented in WT females compared to males, in 
agreement with bibliography (Bastida et al. 2007; Vasan et al. 2004). In contrast 
GABAB1KO females presented significantly lower serum corticosterone, thus losing 
the expected gender difference. Anyway, these results cannot justify the genotype 
differences observed in glucose disposal.  One possible explanation of the discrepancy 
in GTTs and ITTs with respect to glycemia and serum insulin is the fact that 
GABAB1KO females show persistent estrus (Catalano et al. 2010), an estrous cycle 
stage characterized by low serum estradiol (Neill 1980); this can also explain the 
differences observed in corticosterone, given that estrus is also characterized by lower 
levels of this glucocorticoid (Atkinson and Waddell 1997). Regarding the effects of 
estradiol on insulin resistance, Bruns and Kemnitz (Bruns and Kemnitz 2004) described 
that women in the luteal phase, characterized by lower serum estradiol, have decreased 
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insulin sensitivity during a GTT. Additionally, the authors also described diminished 
insulin sensitivity and disposition during a GTT in the luteal phase of female monkeys. 
Hence, we suggest that GABAB1KO females do not have primary insulin resistance but 
the diminished sensitivity observed is secondary to alterations in their reproductive axis, 
which we have previously described (Catalano et al. 2005; Catalano et al. 2010). The 
protective effect of estradiol against the development of insulin-resistance and diabetes 
mellitus is widely discussed in bibliography (Prasannarong et al. 2012; Sakata et al. 
2010). In this regard we can postulate that, even in estrus, females, both GABAB1KO and 
WT, are less prone to develop these conditions than males, and this can explain the gender 
differences we observed in glucose tolerance and insulin sensitivity. This hypothesis is 
also strongly supported by the lack of modification in the insulin signaling pathway in 
skeletal muscle, although alterations in other insulin sensitive tissues such as adipose or 
liver may be involved in the weak disturbances observed in GABAB1KO females. 
So far, we conclude that male GABAB1KO mice present a clear insulin-resistance 
syndrome probably developed as a consequence of persistent insulin secretion, while 
female GABAB1KO mice present some features of diminished insulin sensitivity, which 
are not due to augmented insulin, and probably due to alterations in the reproductive axis. 
The mechanisms involved in the regulation of energy metabolism are complex and 
varied. GABA modulates the expression/release of several factors that modulate food 
intake and its effect varies in different hypothalamic areas and also depends on the 
GABA receptor involved (Ebenezer 2012; Kamatchi and Rathanaswami 2012; Perdona' 
et al. 2011; Stanley et al. 2011). NPY is among the most studied orexigenic factors 
(Kalra and Kalra 2004; Mercer et al. 2011; van den Pol 2003) and is also regulated by 
GABA (Sato et al. 2005). We found an increase in food intake in GABAB1KO animals 
compared to WTs. This increase, however, was not accompanied by weight gain, 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 17 
indicating that the energy balance might be altered in these mice possibly due to 
increased locomotor activity described previously (Schuler et al. 2001). Based on these 
results, we evaluated the expression of NPY in MBH finding a significant increase in 
GABAB1KO mice of both genders. Some studies have postulated that GABA acting on 
GABAB receptors decreases food intake (Perdona' et al. 2011). Therefore, lack of 
functional GABAB receptors may have induced the increase in food intake. Others have 
determined that GABA has orexigenic effects in the ventromedial hypothalamus 
(Perdona' et al. 2011). In this regard, several authors described that muscimol, given 
ICV or directly in ventromedial hypothalamus or paraventricular nucleus, induced 
increases in food intake (Choquette et al. 2009; Jonaidi et al. 2012; Kalra and Kalra 
2004; King 2006). Lack of RGABAB expression may also cause changes in other 
components of the GABA system; our laboratory has described an increase in GAD67 
mRNA in MBH (Catalano et al. 2010), so an increase in GABA content could be 
expected and this could also justify the increase in food intake. Moreover, NPY neurons 
in the arcuate nucleus that monitor serum glucose levels have GABAergic innervation, 
and GABA, through GABAB and A receptors, inhibits neuron activity attenuating the 
orexigenic effects of NPY (Muroya et al. 2005). Therefore lack of GABAB receptors 
could have potentiated the effect of NPY on food intake. In addition, Sato et al also 
suggest that insulin increased GABA release, which in turn acted on GABABRs to 
suppress NPY gene expression (Sato et al. 2005). These results are in agreement with 
our findings since the lack of inhibition due to GABABR absence may have lead to an 
increase in NPY expression and the consequent increase in food intake.  
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Conclusion 
In sum, the absence of functional GABAB receptors induce multiple, sex-dependent 
metabolic alterations put into evidence in the GABAB1KO mouse. GABAB1KO males 
share many characteristics with the insulin resistance syndrome, including increased 
fasted insulin and HOMA-IR, dysfunctional GTTs and ITTs and peripheral 
desensitization to insulin-stimulated AKT phophorylation, as well as increased food 
intake, although these parameters do not lead to weight increase. The female phenotype 
is less severe showing mild food intake increase and glucose intolerance, this last 
condition being possibly secondary to reproductive disruptions. These observations 
further emphasize the importance of GABA and its GABAB receptors in metabolic 
regulation and reinforce the gender differences often observed in related diseases. 
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Figure legends 
Figure 1. A) Area under the curve (AUC) for the glucose tolerance test (AUC GTT). 
Two-way ANOVA: interaction: NS, factor sex (#): p<0.02, genotype (*): p<0.002. B) 
AUC for the insulin secretion test (AUC IST). Two-way ANOVA: interaction: NS, 
factor sex: p<0.001, genotype: NS. C: AUC for insulin tolerance test (AUC ITT), Two-
way ANOVA: interaction: NS, factor sex: p<0.01, factor genotype: p<0.01. D) AUC for 
the glucagon secretion test (AUC GST). Two-way ANOVA: interaction: NS; factor sex: 
p<0.04, factor genotype: NS.  
Figure 2. Basal serum levels of hyperglycemic hormones. A) GH: two-way ANOVA: 
NS; B) Glucagon: two-way ANOVA: NS; C) Corticosterone: two-way ANOVA: 
interaction, p<0.01, *: WT females significantly different form all groups, p<0.05 or less. 
Figure 3.  Expression of proteins involved in the insulin signaling pathway in skeletal muscle. 
A) IRS-1, B) IRS-2, C) IR and D) Hexokinase. In all cases two-way ANOVA: NS. 
Figure 4. Insulin-induced Akt activation in skeletal muscle. Females: two-way 
ANOVA: interaction: NS, factor genotype: NS, factor time: p<0.01, a: 1 and 5 min 
significantly different from 0 min, p<0.01. Males: two-way ANOVA: interaction: 
p<0.04, *: WT males at 5 min significantly different from 0 and 1 min, p<0.02; a: WT 
males at 5 min significantly different from GABAB1KO males at 5 min, p<0.01 
Figure 5. A) Food Intake (g/BW(g)). Two-way ANOVA: interaction: NS, factor sex: 
NS, factor genotype: p<0.03, *: GABAB1KO different from WT. B) Hypothalamic 
NPY mRNA expression. Two-way ANOVA: interaction: NS, factor sex: NS, factor 
genotype: p<0.04, *: KO different from WT. 
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Fig. 2 
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Fig. 5 
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Table I. Basal blood glucose, serum insulin and HOMA-IR index  
 Males Females 
 WT GABAB1KO WT GABAB1KO 
Non-fasted Blood Glucose (mg/dl) 129 ± 4
#
 123 ± 5
#
 103  ± 4 104 ± 6 
Fasted Blood Glucose (mg/dl) 78 ±3 89 ± 9 82 ± 4 86 ± 4 
Non-fasted Serum Insulin (ng/ml) 0.40 ± 0.08
#
 0.41 ± 0.09
#
 0.27 ± 0.05 0.25 ± 0.03 
Fasted Insulin (ng/ml) 0.18 ± 0.03 0.45 ± 0.11* 0.14 ± 0.02 0.14 ± 0.02 
HOMA-IR 0.84 ± 0.16 2.24 ± 0.48* 0.63 ±0.07 0.59 ± 0.08 
 
Values are expressed as Media ± SEM. Non-fasted blood glucose: two-way ANOVA: 
interaction: NS, factor sex: #: p<0.001, factor genotype: NS. Non-fasted serum insulin: 
two-way ANOVA: interaction: NS, factor sex: #: p<0.05, factor genotype: NS. Fasted 
serum insulin: two-way ANOVA: interaction: p<0.04, *: GABAB1KO males different 
from the other groups, p<0.01 or less. HOMA-IR: two-way ANOVA: interaction: 
p<0.03, *: GABAB1KO males different from the other groups, p<0.03 or less. Number 
of animals: 15-20 animals each group. 
